NCT01977443View on ClinicalTrials.gov

Therapeutic Efficacy of APD-209 Eye Drops in Treatment of Epidemic Keratoconjunctivitis (EKC)

PHASE2CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Viral Conjunctivitis
Interventions
DRUG

APD-209 Eye drops

DRUG

APD-209 Placebo Eye drops

Trial Locations (10)

12200

Augenklinik Universitätzmedizin Charité, Berlin

23538

Universitäts-klinikum Schleswig-Holstein, Lübeck

40225

Universitätsklinikum Düsseldorf, Düsseldorf

51109

Augenklinik Köln, Merheim, Cologne

72026

Augenklinik, Universitätsklinikum Tübingen, Tübingen

79106

Universitäts-Augenklinik Freiburg, Freiburg im Breisgau

97080

Universitäts-Augenklinik, Würzburg

40-514

Katowice University Hospital, Katowice

33-100

P. Oleksy Centrum Medyczne Uno-Med, Tarnów

Unknown

St Eriks Eye Hospital, Stockholm

Sponsors

Lead Sponsor

Adenovir Pharma AB
All Listed Sponsors
collaborator

TFS Trial Form Support

INDUSTRY

lead

Adenovir Pharma AB

INDUSTRY

NCT01977443 - Therapeutic Efficacy of APD-209 Eye Drops in Treatment of Epidemic Keratoconjunctivitis (EKC) | Biotech Hunter | Biotech Hunter